ABCL vs EL · rev $28.8M vs rev $15.05B
Abcellera Biologics Inc (ABCL) versus Estee Lauder Companies Inc (EL) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
Latest reported ABCL revenue for 2024-12-31 was $28.8M. Net income was -$162.9M. Revenue was down 24.2% from 2023-12-31 to 2024-12-31. ABCL currently screens at market cap $1.12B.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
ABCL currently screens at market cap $1.12B. EL currently screens at market cap $31.92B.
Not investment advice. Open the ABCL and EL stock pages for the full models.
Not investment advice.